CINGW (STOCKS)
Cingulate Inc. Warrants
$0.026000
-0.000600 (-2.26%)
Prev close: $0.026600
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals Major
- CEO
- Shane J. Schaffer, PharmD
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- —
- Employees
- 13
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | -$1.36M |
| Benefits Costs and Expenses | $21.09M |
| Costs And Expenses | $21.09M |
| Operating Expenses | $18.58M |
| Research and Development | $9.77M |
| Other Operating Expenses | $8.80M |
| Operating Income/Loss | -$19.94M |
| Income/Loss From Continuing Operations After Tax | -$22.45M |
| Income/Loss From Continuing Operations Before Tax | -$22.45M |
| Interest Income/Expense After Provision For Losses | -$1.36M |
| Interest Income/Expense Operating, Net | -$1.36M |
| Net Income/Loss | -$22.45M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$22.45M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.45M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$4.44 |
| Diluted Earnings Per Share | -$4.44 |
| Basic Average Shares | 5,055,329 |
| Diluted Average Shares | 5,055,329 |
| Assets | $15.07M |
| Current Assets | $12.01M |
| Noncurrent Assets | $3.07M |
| Fixed Assets | $1.73M |
| Other Non-current Assets | $1.34M |
| Liabilities | $12.56M |
| Current Liabilities | $10.31M |
| Accounts Payable | $2.04M |
| Other Current Liabilities | $8.28M |
| Noncurrent Liabilities | $2.25M |
| Equity | $2.51M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $2.51M |
| Liabilities And Equity | $15.07M |
| Net Cash Flow From Operating Activities | -$17.25M |
| Net Cash Flow From Operating Activities, Continuing | -$17.25M |
| Net Cash Flow From Investing Activities | -$162.14K |
| Net Cash Flow From Investing Activities, Continuing | -$162.14K |
| Net Cash Flow From Financing Activities | $16.15M |
| Net Cash Flow From Financing Activities, Continuing | $16.15M |
| Net Cash Flow | -$1.26M |
| Net Cash Flow, Continuing | -$1.26M |
| Comprehensive Income/Loss | -$22.45M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$22.45M |
| Other Comprehensive Income/Loss | $0.00 |